H ypertriglyceridemia is characterized by the accumulation of triglyceride-rich lipoproteins (TRLs) in the blood. This condition affects 10% to 20% of the population in Western countries and increases the risk of atherosclerosis, coronary artery disease, and pancreatitis. [1] [2] [3] [4] TRLs consist of intestinal chylomicrons derived from dietary fats and very low-density lipoproteins (VLDLs) from the liver, as well as remnant particles resulting from the lipolytic processing of these lipoproteins in the peripheral circulation. Clearance of TRL remnants occurs in the liver via a multi-step process. [5] [6] [7] The particles first pass through the fenestrated endothelium of the liver sinusoids and become sequestered in the perisinusoidal space of Disse, where they undergo further processing by lipoprotein lipase and hepatic lipase. 6 Particles are then cleared by endocytic receptors on the surface of hepatocytes, leading to their lysosomal catabolism. Several receptors for remnant lipoproteins have been identified, including the lowdensity lipoprotein receptor (LDLR), 8 members of the LDLRrelated protein family (LRP1 and LRP5), 9 ,10 syndecan-1, 11 a type of heparan sulfate proteoglycan (HSPG), the very lowdensity lipoprotein receptor (VLDLR), 12 scavenger receptor B1, 13 and lipolysis-stimulated receptor. 14 Understanding the relative contribution of these receptors to clearance, their coordinate regulation, and their role in maintaining plasma lipids under different dietary conditions is important because the information could help focus future drug development efforts to reduce hypertriglyceridemia.
In the present study, we sought to understand the relative contributions of HSPGs, LDLR, and LRP1 to clearance of remnant lipoproteins under various dietary conditions in mice. To this end, we interbred mice deficient in Ldlr, Lrp1, and the gene N-acetylglucosamine Objective-Chylomicron and very low-density lipoprotein remnants are cleared from the circulation in the liver by heparan sulfate proteoglycan (HSPG) receptors (syndecan-1), the low-density lipoprotein receptor (LDLR), and LDLR-related protein-1 (LRP1), but the relative contribution of each class of receptors under different dietary conditions remains unclear. Approach and Results-Triglyceride-rich lipoprotein clearance was measured in AlbCre ) displayed dramatic hyperlipidemia (870±270 mg triglyceride/dL; 1300±350 mg of total cholesterol/dL) and exhibited persistent elevated postprandial triglyceride levels because of reduced hepatic clearance. Analysis of the particles accumulating in mutants showed that HSPGs preferentially clear a subset of small triglyceride-rich lipoproteins (≈20-40 nm diameter), whereas LDLR and LRP1 clear larger particles (≈40-60 nm diameter). Finally, we show that HSPGs play a major role in clearance of triglyceride-rich lipoproteins in mice fed normal chow or under postprandial conditions but seem to play a less significant role on a high-fat diet. 
Conclusions-These

Materials and Methods
Materials and methods are available in the online-only Supplement.
Results
Inactivation of Ldlr, Lrp1, and Ndst1
We previously described mice in which the Cre transgene under the control of the albumin promoter was used to inactivate the heparan sulfate biosynthetic enzyme Ndst1 selectively in hepatocytes. 15 Ndst1 affects the sulfation of all HSPGs including syndecan-1, the primary hepatic proteoglycan receptor. 11 Like Sdc1 −/− mice, AlbCre + Ndst1 f/f mice display a 2-fold accumulation of fasting triglycerides and have delayed clearance of postprandial triglycerides because of loss of sulfation of the heparan sulfate chains located on syndecan-1 specifically in the liver. 11 Syndecan-1 knockout mice were not used in this study because a conditional mutant has not been described. Liver Figure 1A ). LRP1 and LDLR expression exhibited some variability in wild-type and HSPG receptor-deficient mice. However, when normalized to β-actin their levels of expression were not significantly different in any of the strains, indicating that altering HSPG receptor activity by inactivation of Ndst1 did not cause any compensatory changes in these receptors ( Figure 1B and 1C) . Similarly, hepatic syndecan-1 expression was not affected by inactivation of Ldlr, Lrp1, or Ndst1 and any combination of mutations in these genes ( Figure 1D) . Thus, the expression of syndecan-1 and LDLR family members does not seem to occur in a coordinated manner in hepatocytes under these conditions.
Hyperlipidemia in Compound Mutant Mice
To study the relative contribution of the 3 receptors to clearance of TRLs, we first analyzed plasma triglyceride and cholesterol in blood drawn from overnight-fasted animals raised on a normal chow diet ( Figure 2 ; Table 2 ). HSPG receptor-deficient mice (Cre + Ndst1 f/f ) accumulated triglycerides compared with wild-type animals ( Figure 2A ; 69±26 versus 43±10 mg/ dL, respectively; P<0.01), as shown previously. 15 In contrast, mice lacking hepatic LRP1 (Cre + Lrp1 f/f ) did not accumulate plasma triglycerides (Figure 2A Heparan sulfate purified from isolated hepatocytes was digested with heparin lyases I, II, and III. The resulting disaccharides were derivatized with isotopically labeled aniline and quantified by mass spectrometry (see Methods in the online-only Data Supplement). Disaccharides are designated using the code established in reference 17. Those containing the letter S contain a N-sulfate group. HSPG indicates heparan sulfate proteoglycan; LDLR, low-density lipoprotein receptor; LRP1, LDLR-related protein-1; and Ndst1, N-acetylglucosamine N-deacetylase-N-sulfotransferase-1. Ldlr −/− ). These findings suggest that LRP1 does not play a major role in TRL clearance when LDLR is present, consistent with previous studies. 9, 18 HSPGs are not thought to contribute to clearance of cholesterol-rich lipoprotein particles on the basis of the observation that HSPG receptor-deficient mice (Cre 
≈4-fold over wild type (Figure 2B
;
HSPGs and LDL Receptor Family Members Mediate Clearance of TRLs of Unique Size
The accumulation of TRLs in single mutants deficient either in HSPGs or in LDLR suggested that these receptors can clear different subsets of TRLs. We recently showed that HSPG receptor-deficient mice accumulate particles enriched in apoAV, whereas animals lacking LDLR and LRP1 do not. 19 To study the composition of these particles in greater detail, Figure 1 . Inactivation of low-density lipoprotein receptor (Ldlr) and LDLR-related protein-1 (Lrp1) in compound mutant mice. A, Fresh hepatocytes were isolated from 12-week-old male mice and solubilized in radio-immunoprecipitation assay buffer. Samples were separated by gradient SDS-PAGE and transferred to polyvinylidene difluoride membranes. The membrane was probed with antibodies against LDLR, LRP1, syndecan-1 (SDC1), and β-actin. Each lane represents a different mouse (n=3 per genotype). B-D, Densitometry analysis of the Western blots presented in A. LRP1 and LDLR protein expression is not detected in the relevant mutants, whereas SDC1 is detected at comparable levels in all of the strains. Ndst1 indicates N-acetylglucosamine N-deacetylase-N-sulfotransferase-1.
we analyzed samples by agarose electrophoresis, gel filtration, ultracentrifugation, and electron microscopy.
First, we analyzed TRLs (δ<1.006 g/mL) using nondenaturing agarose gel electrophoresis, which separates particles dependent on size and charge ( Figure 3A ). Wild-type TRLs migrated furthest, whereas the migration of TRLs that accumulated in HSPG receptor-deficient mice (Cre or cholesterol was noted in any of the mutants by this method ( Figure 3B and 3C) .
Higher resolution was achieved by evaluating the size of TRLs (δ<1.006 g/mL) by transmission electron microscopy ( Figure 3D ). Mice lacking HSPG receptors accumulated a range of particles, predominantly 20 to 50 nm in diameter. In contrast, the mutant lacking both LDLR family members (Cre Finally, purified TRLs (d<1.006 g/mL) were analyzed by gradient SDS-PAGE, and the individual apolipoproteins were visualized by silver staining. In all mutants, the TRLs contained apoB48, apoB100, apoE, and various apoCs ( Figure 3E ). In Cre
+
Ndst1
f/f mice, both apoB48 and apoB100-containing lipoproteins accumulated. Combined inactivation of Ldlr and Lrp1 (Cre f/f mutant. We further characterized the apolipoprotein composition of accumulated Figure 3 . Sizing of accumulated particles. A, Lipoproteins of δ<1.006 g/mL (pooled from n=3 mice per each genotype) were isolated by buoyant density ultracentrifugation and were analyzed by nondenaturing agarose electrophoresis. Asterisk indicates location of the origin. Lipoproteins were analyzed by gel filtration fast-phase liquid chromatography, and the amount of (B) triglyceride and (C) cholesterol in each fraction was measured. The elution positions of human chylomicron remnant (CR)/very low-density lipoprotein (VLDL), intermediate density lipoprotein (IDL)/low-density lipoprotein (LDL), and high-density lipoprotein (HDL) are indicated. D, Triglyceride-rich lipoproteins (δ<1.006 g/mL) were negatively stained with 1% uranyl acetate and particle size was analyzed using images obtained by transmission electron microscopy. The diameters of particles present in 5 to 6 fields (1000-2000 particles per genotype) were measured using ImageJ software. The difference in distribution of particle size was significant between all groups by Kruskal-Wallis test except between the Cre ). E, Samples of pooled lipoproteins of δ<1.006 g/mL (n=3 per genotype) were analyzed by gradient SDS-PAGE, and the individual lipoproteins were visualized by silver staining. The location of apolipoprotein B48 (apoB48), apoB100, apoE, and apoCs was deduced by relative molar mass values. F, Samples of purified lipoproteins of δ<1.006 g/mL were analyzed by gradient SDS-PAGE, and the individual lipoproteins were visualized by Western blotting using antibodies against apoB, apoE, and apoAV. Representative images from the same gel are shown (n=3 mice per genotype). Ndst1 indicates N-acetylglucosamine N-deacetylase-N-sulfotransferase-1.
particles by Western blot ( Figure 3F) 19 Together, these data suggest that HSPGs preferentially clear a subset of small TRL particles enriched in apoAV and apoE, whereas members of the LDLR family of receptors clear large particles, enriched in apoE, as reported previously. 8 
Postprandial Triglyceride Clearance and Liver Uptake Is Significantly Delayed in Compound Mutant Mice
We next examined how receptor inactivation affected postprandial clearance. Fasted mice were given a bolus of corn oil by oral gavage, and blood was sampled at various time points post gavage to measure appearance and disappearance of triglycerides in the circulation. As shown in Figure 4A , HSPG receptor-deficient mice (Cre To verify that this delay in postprandial clearance was because of altered liver clearance, we performed a [ Figure 4B ). In a separate experiment, counts remained significantly elevated in plasma from the triple receptor-deficient mice even 24-hour post gavage. Correspondingly, liver uptake of the radioactive TRLs was decreased compared with the wild type, with very low uptake occurring in livers from triple receptor-deficient mice ( Figure 4C ). There was no significant difference in uptake of radioactive counts into skeletal muscle or heart between the wild type and any of the mutants ( Figure 4D and 4E) , confirming that that the observed persistence of postprandial triglycerides was because of defective clearance by hepatic receptors.
High-Fat Diet Shifts the Relative Contribution of HSPG Receptors and LDL Receptor Family Members to TRL Clearance
In a final set of experiments we examined how the various mutants would respond to a Western diet, high in fat and cholesterol content. Twelve-week-old mice were put on the Western diet and blood was taken for lipid analysis at 0, 1, 4, and 6 weeks after a short fasting period ( Figure 5 ; Table 3 ). The Western diet induced little to no change in triglyceride levels of wild-type mice (65±3 mg/dL at t=0-82±10 mg/dL after 6 weeks on the Western diet; P>0.1). HSPG receptor-deficient mice exhibited a 2-fold increase in triglyceride levels after 6 weeks on the Western diet (82±7-172±30 mg/dL; P<0.05). This change was mild in comparison with the increase seen in mice lacking LDLR and LRP1. In the absence of these receptors, plasma triglycerides increased at all time points, from 497±39 at the start of the Western diet to 1990±135 mg/dL after 6 weeks. Inactivation of all 3 receptors increased plasma triglyceride to a similar level from 644±57 to 1850±170 mg/dL.
The Western diet also increased plasma cholesterol in Cre
Ldlr −/− mice from 550±40 mg/dL at the start of the experiment to 2500±110 mg/dL after 6 weeks (P<0.001). The triple mutant was affected similarly (710±60 mg/dL increasing to 2500±220 mg/dL; P<0.001). The majority of the cholesterol was associated with the LDL fraction on the basis of gel filtration ( Figure 5E ). Plasma cholesterol levels increased slightly during high-fat feeding in both wild-type (72±4-130±14) and HSPG receptor-deficient mice (90±8-200±37; Figure 5b ). Apolipoprotein analysis of purified TRLs (d<1.006 g/mL) by gradient SDS-PAGE and silver staining showed that the Cre +
Ndst1
f/f mutant accumulated apoB 100 and apoE-containing lipoproteins ( Figure 5C ), whereas mutants lacking Ldlr (Cre Figure 5F ). Together the data suggest that the LDLR family members play a dominant role in TRL clearance when mice consume a high-fat/high-cholesterol diet, whereas HSPGs play a more significant role when the animals are fed normal chow.
Discussion
A large body of work has established a role for HSPGs in hepatic clearance of TRL remnants. In cultured cells, HSPGs can interact directly with apolipoproteins and lipases and facilitate their internalization by endocytosis. [20] [21] [22] Reduced plasma clearance rates and reduced hepatic uptake of labeled VLDL have been observed in mice after intravenous infusion with agents that neutralize heparan sulfate such as heparinase, heparin, suramin, or lactoferrin. [23] [24] [25] ApoE variants have been described in which patients exhibit severe hyperlipoproteinemia, which has been associated with altered binding to heparan sulfate. 23, 26, 27 Recently, we showed that Cre-mediated inactivation of Ndst1 or uronyl 2-O-sulfotransferase (Hs2st) in hepatocytes results in the accumulation of fasting triglycerides and delayed clearance of intestinally derived lipoproteins because of undersulfation of heparan sulfate. 15, 28 In subsequent studies, we identified syndecan-1 as the primary HSPG receptor for TRLs in mouse and human hepatocytes.
11,29
Members of the LDL receptor family have also been demonstrated to act as receptors for remnant lipoprotein clearance. LDLR was originally characterized as a receptor for cholesterol-rich apoB100-and apoE-containing particles such as LDL. Mice, rabbits, and humans deficient for LDLR have only modest accumulation of triglycerides, suggesting a less dominant role for LDLR in TRL metabolism as compared with LDL metabolism. 8, 30, 31 Hepatocytes also express LRP1, which was thought to participate in clearance of apoE-enriched apoB 48 -bearing lipoproteins, including TRLs. 32 However, hepatocytespecific ablation of Lrp1 does not result in accumulation of fasting triglycerides or cholesterol ( Figure 1 ; Table 2 ). A role for LRP1 becomes evident when LDLR is deficient (eg, in Cre
Ldlr −/− mice and when Lrp1 was inactivated by injection of Adenoviral-Cre). 9 In other studies, in vivo inhibition of LDLR was achieved using tail vein injection of a blocking antibody. 33 This treatment reduced plasma clearance of TRLs by ≈45%, whereas injection of the receptor-associated protein, an inhibitor of LRP1, reduced plasma clearance by 55%. When the LDLR blocking antibody and receptor-associated protein were administered together, plasma removal was only decreased by 60%, an incremental effect at best. In a different study, mice with systemic deletions of Vldlr and Ldlr were bred to mice in which Lrp1 was inactivated by an inducible Cre. 34 VLDLR is not expressed in the liver and has been shown to mediate TRL clearance in tissues active in fatty acid metabolism (heart, adipose, and skeletal muscle). Notably, heparin blocked the association of DiI-labeled lipoproteins to hepatocytes from the deficient mice. These findings are consistent with our conclusions that HSPG receptors are a major contributor to clearance in the liver, and that the 2 receptor families do not fully compensate for one another.
Our genetic analysis of the relative contribution of HSPG receptors and LDLR and LRP1 to TRL clearance has several important implications. On the basis of fasting triglyceride data from double and triple mutant mice (Figure 2) , we conclude that LDLR, LRP1, and HSPGs are the major TRL clearance receptors in mice, although the role of LRP1 only becomes apparent in the absence of LDLR. Postprandial clearance data also support this conclusion (Figure 4) . In triple receptor-deficient mice, triglyceride levels remain elevated and liver uptake remains low even 8-hour post gavage, suggesting that other TRL receptors, such as lipolysis-stimulated receptor, LRP5, VLDLR, or scavenger receptor B1, do not compensate for the absence of these 3 major receptors. Nevertheless, we cannot exclude the possibility that these other receptors play a role in clearance under other conditions that were not addressed in our studies. 10, 13, 35 Our findings also suggest that the different receptor subtypes clear distinct subsets of lipoprotein particles. On the basis of electron microscopy studies of particles that accumulate in the mutants, HSPG receptors apparently clear a subset of smaller TRLs, whereas members of the LDLR family of receptors clear larger particles (Figure 3 ). The idea that particle size partially determines the affinity of lipoprotein particles for their 3 H]retinol mixed with corn oil by oral gavage. After 8 hours, blood was obtained by cardiac puncture and plasma was assayed for radioactivity by liquid scintillation counting (B). Subsequently, the mice were euthanized and dissected. Organs were weighed, homogenized, and assayed for radioactivity. Counts per milligram of tissue are reported for (C) liver, (D) muscle, and (E) heart. No statistically significant difference in uptake was observed in muscle or heart among the mutants (n=3 mice per genotype). LDLR indicates low-density lipoprotein receptor; LRP1, LDLR-related protein-1; and Ndst1, N-acetylglucosamine N-deacetylase-N-sulfotransferase-1.
receptors has been suggested 36 and may be the result of apolipoprotein conformation or content. In this study, we provide additional evidence showing that HSPGs preferentially clear particles that are enriched in apoE and apoAV. 19 On the basis of our findings, we suggest that the small particles preferentially cleared by HSPG receptors are enriched for apoE and apoAV.
Whether these particles have other unique attributes is unknown. Conceivably, these particles might originate from lipolysis of a unique pool of VLDL or chylomicrons in the vasculature.
HSPGs can act as independent endocytic receptors for numerous ligands. [37] [38] [39] Nevertheless, the idea that HSPGs act independently of other receptors in TRL clearance has All values are expressed as average±SE. HSPG indicates heparan sulfate proteoglycan; LDLR, low-density lipoprotein receptor; LRP1, LDLR-related protein-1; and Ndst1, N-acetylglucosamine N-deacetylase-N-sulfotransferase-1. been questioned. 6, 40 Biochemical data have been presented suggesting that these 2 proteins act as coreceptors for lipoprotein particles or participate in a handoff process whereby HSPGs trap lipoprotein particles in the space of Disse and subsequently transfer them to LRP1 for endocytosis. 6 Given our findings that the receptors clear different subsets of particles and that syndecan-1 expression is not affected by the loss of LDLR and LRP1 in hepatocytes (and vice versa), it seems likely that each receptor family acts independently.
The prominent role of syndecan-1 in clearance under fasting and postprandial conditions predicted that the proteoglycans would play an important role in clearing remnant lipoproteins in animals fed a Western diet. Surprisingly, triglyceride and cholesterol levels in HSPG receptor-deficient mice hardly changed when fed a Western diet. This is in sharp contrast to LDLR/LRP1-deficient mice in which high-fat feeding drastically increased both cholesterol and triglyceride levels. Furthermore, our data show that this discrepancy could not be explained by drastic changes in apolipoprotein composition of TRLs or changes in hepatic expression of LDLR, LRP1, scavenger receptor B1, and lipolysis-stimulated receptor in HSPG receptor-deficient mice on the Western diet. One interpretation of these findings is that hepatic HSPG receptors are active under basal (chow-fed) conditions and in response to acute dietary changes, that is, postprandial lipid loading, but do not recognize the particles that accumulate under chronic high-fat feeding. Conceivably, high levels of circulating LDL particles that accumulate under these conditions could decrease the availability of apoE and apoAV or shift particle size toward substrates poorly recognized by syndecan-1. We cannot exclude that changes in TRL lipid composition or the increase in blood lipids per se are contributing to this intriguing observation. Additional studies are clearly warranted to determine whether increasing the expression of apoE and or apoAV pharmacologically stimulates HSPG-mediated clearance under high-fat diet conditions. 3 The triple receptor-deficient mouse represents a unique hyperlipidemic model that can be used to study triglyceride and cholesterol metabolism under conditions where clearance is greatly delayed. In addition, the triple receptor mutant may prove to be a valuable tool for elaborating the mechanism of action of compounds that reduce or prevent atherosclerosis independent of hepatic TRL clearance.
